Home / Intelligence

Type
  • All
  • Analyst Reports
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Customer Engagement
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • Medical Affairs
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Sustainability
  • Talent Acquisition and Retention
  • United States
  • Value Communication
Search

Webinars

Health Equity in HTA Outcomes: Navigating the New Frontier

April 30, 2025 | 11:00 - 11:45 AM ET / 17:00 - 17:45 CET

Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.

Sign Up Now

Webinars

Health Equity in HTA Outcomes: Navigating the New Frontier

April 30, 2025 | 11:00 - 11:45 AM ET / 17:00 - 17:45 CET

A second session will be offered: May 1 at 16:00-16:45 (UTC +8:00) – Asia/Shanghai Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.This session will explore how HTA agencies are beginning to include health equity in their access recommendations and discuss…

Sign Up Now

Blog

The Evolution of CRM in Life Sciences: Navigating the Split

Published April 8, 2025

A Massive Change in Customer Relationship Management (CRM) Software The split between Veeva and Salesforce marks a significant shift in the CRM landscape. Veeva is removing its CRM from the Salesforce cloud in September 2025 to focus on its “Veeva Vault” cloud solution for CRM. Veeva has communicated that it will maintain the current CRM product until September 2030 but will not be making any updates—and that it will absorb the cost of migration to the new Vault platform for…

Read Now

Analyst Reports

Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences

Everest Group report: AI-deas to Action: Operationalizing Generative AI in Life Sciences This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included. The report highlights several of Trinity’s key strengths, including: Life Sciences Industry Expertise Trinity has nearly 30 years of experience in the industry, providing evidence-based solutions to over 300 clients, including the global top 20 biopharma companies. This deep…

Read Now

Blog

Trinity Life Sciences & Snowflake: Advancing Pharmaceutical Insights

Published March 27, 2025

Trinity Life Sciences and Snowflake recently released an exciting blog highlighting a case study that illustrates how their partnership built the data foundation for Trinity RealWorldEDGE and Real Insights. These offerings enable clients to quickly and easily access patient-level data from any source for insight generation–and allow clients to unlock the potential of predictive insights grounded in market research and real-world data. Excerpt How did Snowflake and Snowpark transform Trinity’s vision into reality? Data collaboration is critical to the success…

Read Now

Blog

Medical Affairs Customer Engagement: What’s Next?

Published March 19, 2025

Medical Affairs teams are increasingly harnessing the power of omnichannel communication and orchestrated customer engagement to enhance interactions with key stakeholders. Changing customer preferences and access to content are key factors Medical Affairs teams are addressing by adopting more customer engagement channels. As these capabilities continue to expand, it is important for teams to embrace a strategic mix of field medical engagements, digital platforms, personalized messaging, non-personal engagement and seamless coordination across channels. By adopting an omnichannel strategy, Medical Affairs…

Read Now

Webinars

Launch & Learn: Trinity Launch Accelerator

Available On Demand

Today’s launch environment is fraught with greater complexity, lack of standardization and executional inefficiency. Join Trinity Life Sciences for a virtual “launch and learn” where Krista Perry—Partner & Head of Launch Excellence and Tarra Maeshima— Sr. Director of New Products & Strategy share how Trinity Launch Accelerator enables teams to overcome these typical launch barriers with a simple and clear launch readiness and management process. Trinity’s Launch Accelerator is the industry’s first and only benchmark-based launch tool, built by experts…

Watch Now

Webinars

Trinity Annual Drug Index

White Paper & On-demand Webinar: This report, the seventh in our Trinity Drug Index series, outlines key themes and emerging trends in the industry as we progress towards a new world of targeted and innovative products. We provide a comprehensive evaluation of the performance of novel drugs approved by the FDA in 2021, scoring each on its commercial performance, therapeutic value and R&D investment. 2021 saw 40 unique drug and biologic approvals, of which ~33% (13/40) were Oncology, followed by…

Read Now

Webinars

RWD Expertise x Technology = Enhanced Patient Outcomes

Available On Demand

The addition of real-world data (RWD) to other data streams through technology allows the patient impact to be magnified many times. Combined with PMR, RWD can drive exceptional insights and accuracy in demand assessments, segmentation, message testing, market mapping and ATUs. Amplified with GenAI and solutions like Real Insights and RealWorldEDGE, the range of RWD-powered use cases broadens even further. Join Rajeev Rangachari, CTO of Trinity Life Sciences, as he hosts a wide-ranging discussion on enabling exponential outcomes with RWD…

Watch Now

Blog

Culture and Collaboration: Keys to Customer Engagement Success

Published February 27, 2025

We’re delighted to bring an external expert perspective to the “One Chapter Ahead” blog series and the important topic of culture and collaboration. Amy Saunders is a recognized customer experience global leader across life science verticals including pharma, med devices and consumer packaged goods (CPG) for companies such as J&J Consumer, W.L. Gore and Novartis. Most recently, Amy established and led the Customer Experience function at Novartis International which encompassed customer experience (Cx) strategy, engagement planning and production, patient support…

Read Now

Webinars

Virtual Demo | HTA Vision with GenAI

Available On Demand

Join Trinity Life Sciences for a virtual demo where value, access and pricing experts Max Hunt and Andreia Ribeiro will demonstrate Trinity HTA Vision, our cloud-based dashboard with GenAI capabilities.It is not enough to know what the health technology assessment (HTA) decisions are and when they are made—with the landscape continually evolving, analogues and future impact cannot be judged by looking at decisions alone. Nuanced implications come from expert knowledge of countries/agencies, therapeutic areas and lifecycle stage.Discover the power of HTA…

Watch Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.